Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study

Introduction: To analyze the feasibility and efficacy of sleeve lobectomy after neoadjuvant immunotherapy in multicenter patients with squamous cell lung cancer. Methods: We retrospectively identified patients who received neoadjuvant immunotherapy (n = 14) or chemotherapy alone (n = 33) at five tho...

Description complète

Détails bibliographiques

Auteurs principaux:	Tianxiang Chen, MD, PhD, Junwei Ning, MD, Jianfei Shen, MD, PhD, Hui Pan, MD, Linhai Fu, MD, Enwu Xu, MD, PhD, Han Wu, MD, Jia Huang, MD, PhD, Yunhai Yang, MD, PhD, Ziming Li, MD, PhD, Qingquan Luo, MD, PhD
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2023-04-01
Collection:	JTO Clinical and Research Reports
Sujets:	Neoadjuvant therapy Sleeve lobectomy Squamous cell lung cancer PD-1 inhibitor
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2666364323000115
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!